Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Deveridge

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Archives of Internal Medicine|August 11, 1997
Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemiaI Kerridge, M Lowe, M Seldon, et al.
Bone Marrow Transplantation|March 5, 1998
Collection and analysis of peripheral blood mononuclear cells during haemopoietic recovery following PBSCT for CML: autografting as an in vivo purging manoeuvre?A Spencer, N Granter, K Fagan, et al.
Transfusion|October 6, 1997
Remote electronic blood release systemC Cox, A Enno, S Deveridge, et al.
Bone Marrow Transplantation|March 22, 2005
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantationA Spencer, N Horvath, J Gibson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Archives of Internal Medicine|August 11, 1997
Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemiaI Kerridge, M Lowe, M Seldon, et al.
Bone Marrow Transplantation|March 5, 1998
Collection and analysis of peripheral blood mononuclear cells during haemopoietic recovery following PBSCT for CML: autografting as an in vivo purging manoeuvre?A Spencer, N Granter, K Fagan, et al.
Transfusion|October 6, 1997
Remote electronic blood release systemC Cox, A Enno, S Deveridge, et al.
Bone Marrow Transplantation|March 22, 2005
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantationA Spencer, N Horvath, J Gibson, et al.
Pageof 1